After an over decade-long discourse amongst interested stakeholders, on October 3, 2023, FDA unveiled its proposed rule and policy to increase oversight over LDTs. If finalized as proposed, FDA would ...
Clinical genomics laboratories are no longer limited to research settings; they are increasingly integrated into routine ...